Table of Contents Author Guidelines Submit a Manuscript
International Journal of Cell Biology
Volume 2012 (2012), Article ID 712153, 6 pages
Research Article

Effects of IGF-1 on and Channels via PI3K/Akt Signaling in Neonatal Cardiac Myocytes

Department of Physiology & Biophysics, College of Medicine, Howard University, Washington, DC 20059, USA

Received 31 March 2012; Accepted 17 April 2012

Academic Editor: Shoichiro Ono

Copyright © 2012 Richard M. Millis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Previous studies suggest that sarcolemmal potassium currents play important roles in cardiac hypertrophy. IGF-1 contributes to cardiac hypertrophy via activation of PI3K/Akt signaling. However, the relationships between IGF-1, PI3K/Akt signaling and sarcolemmal potassium currents remain unknown. Therefore, we tested the hypothesis that IGF-1 and PI3K/Akt signaling, independently, decrease sarcolemmal potassium currents in cardiac myocytes of neonatal rats. We compared the delayed outward rectifier ( ) and the inward rectifier ( ) current densities resulting from IGF-1 treatments to those resulting from simulation of PI3K/Akt signaling using adenoviral (Ad) BD110 and wild-type Akt and to those resulting from inhibition of PI3K signaling by LY294002. Ad.BD110 and Ad.Akt decreased and these decrements were attenuated by LY 294002. The IGF-1 treatments decreased both and but only the decrement was attenuated by LY294002. These findings demonstrate that IGF-1 may contribute to cardiac hypertrophy by PI3K/Akt signal transduction mechanisms in neonatal rat cardiomyocytes. Failure of LY294002 to effectively antagonize IGF-1 induced decrements in suggests that a signal pathway adjunct to PI3K/Akt contributes to IGF-1 protection against arrhythmogenesis in these myocytes. Our findings imply that sarcolemmal outward and inward rectifier potassium channels are substrates for IGF-1/PI3K/Akt signal transduction molecules.